Thursday March 9
|
|
7:30 - 8:30
|
Registration – Exhibition Hall
Breakfast – Montreal Room
|
|
8:30 - 8:40
|
Welcome from CellCAN – Regenerative Medicine and Cell Therapy Network
Denis Claude Roy, CEO, CellCAN
Fortifications Room
|
|
8:40 - 9:00
|
Learning from the patients’ perspectives
Moderators:
Michel Rochon, Scientific journalist
Denis Claude Roy, CEO of CellCAN
Patients:
Jennifer Molson, Survivor of multiple sclerosis symptoms
William Brock, Survivor of leukemia
Fortifications Room
|
|
Theme 1: Opportunities and challenges of recent innovations in cell and gene therapy
Moderators:
Michel Rochon, Scientific journalist
Denis Claude Roy, CEO, CellCAN
Fortifications Room
|
|
9:00 - 10:00
|
Innovation in cancer therapy : CAR-T, game changer in cancer treatment?
Overview of the CAR-T revolution
Jerome Ritz, Executive Director, Connell O'Reilly Cell Manipulation at the Dana Farber Cancer Institute
The TAC receptor: Taking a new CAR for a spin
Jonathan Bramson, Director, Fraunhofer Project Centre for Biomedical Engineering and Advanced Manufacturing
|
|
10:00 - 10:30
|
Health break and exhibitors visit
|
|
10:30-11:30
|
Innovation in viral and gene Therapies
Oncolytic virus to promote anticancer activity
John Bell, Senior Scientist, Centre for Innovative Cancer Research, Ottawa Hospital Research Institute
CRISPR/Cas9 may be used to treat hereditary diseases
Jacques Tremblay, Professor in the Department of Molecular Medicine, Laval University
|
|
11:30 -13:00
|
Lunch, networking and exhibitors visit
Montreal Room
|
|
Theme 2: Preparing Canada for the cell and gene revolution
Moderators:
Michel Rochon, Scientific journalist
James Price, President and CEO, Canadian Stem Cell Foundation
Fortifications Room
|
|
13:00 - 13:40
|
Dr. Janet Rossant presents the Council of Canadian Academies (CCA) latest workshop report on the opportunities and challenges for regenerative medicine in Canada
Dr Janet Rossant, President & Scientific Director of the Gairdner Foundation and Chair of the steering committee of the CCA workshop on regenerative medicine
|
|
13:40 - 14:10
|
Key enablers and barriers for cell and gene therapy translation in Canada
Joanne Castonguay, Research Director, Institute for Research on Public Policy (IRPP)
|
|
14:10 - 15:10
|
Panel - Advancing cell therapy through national strategies and initiatives: international examples
The California experience (CIRM)
Geoffrey Lomax, Senior Officer, CIRM Strategic Infrastructure
How Britain makes it work (Catapult)
Dominic Bowers, Head of Clinical Operations & Development, Catapult
Fast-tracking strategies in Japan (Jetro)
Tyson Garbe, Assistant Director, Trade and Investment, JETRO Toronto
|
|
15:10 - 15:30
|
Health break and exhibitors visit
|
|
15:30 - 16:30
|
Parallel workshops: Addressing key elements to engage in the cell and gene therapy revolution
|
| Saint-Antoine Room |
Ville-Marie A Room |
Ville-Marie B Room |
|
Strategically planning for manufacturing changes between early and late clinical trials
Moderator: Patrick Bedford, Manager, Clinical Translation & Regulatory Affairs, CCRM
Nadine Kolas, Senior Policy Analyst, Health Canada
Sowmya Viswanathan, Lead, CellCAN Manufacturing Platform, Assistant Professor, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Affiliate Scientist, Krembil Research Institute, University Health Network
|
Quality gaps in funding requests for translational projects
Phil Welford, Executive Director, Stem Cell Network
|
Ethics and “Cellular Genomics”?
Bartha Knoppers, Director of the Centre of Genomics and Policy at the Faculty of Medicine, McGill University
|
|
|
16:30 - 16:45
|
Report on parallel workshop and wrap-up of the day
Wrap-up of the day
Fortifications Room
|
|
16:45 - 17:00
|
Denis Claude Roy is proud to introduce…
ISCT ANNOUNCEMENT, Queenie Jang, Executive Director, International Society for Cell Therapy
Denis Coderre, Montreal Mayor
|
|
17:00 - 18:30
|
Cocktail - Sponsored by C3i
Exhibition Hall
|